Credibly Small Business Award 2025

The Business or Commercialization Planning assistance micro-grant can reimburse up to $5000, spent on hiring an approved, independent, third party to write a comprehensive business or commercialization plan for a Wisconsin business. Typically awardees are pursuing a Phase II SBIR/STTR grant in which a detailed commercialization plan is required. The program is limited to businesses in certain industries.

Purpose: The Pollution Control Tax-Exempt Bond Financing Program facilitates low cost capital through private activity, tax-exempt bonds. The securities pay for acquisition, construction or installation of qualified pollution control, water furnishing, waste disposal, waste recovery facilities and equipment. Tax-exempt bond financing assists qualified borrowers to obtain lower interest rates than are available through conventional loans. Description: CPCFA acts as a conduit issuer in the transaction. The bonds are issued to raise capital for revenue-generating projects where the funds are used by the borrower to make payments to investors. The conduit financing is typically backed by either the borrower's credit or monies pledged to the project by outside investors. If the project fails and goes into default, it is solely the borrower's responsibility to repay the bondholders.

Indiana’s State Trade and Export Promotion (IN-STEP) Program, eligible businesses can get financial support for developing and expanding their export-related activities. Businesses can get up to 80% of their export-related costs—from trade show fees to marketing expenses—reimbursed, up to $15,000 total.

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants applying for funding under this NOFO should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB) approvals, and establishment of drug (and placebo, if applicable) supplies, and any necessary third-party agreements should be established by the time of award. If time and support for these and other pre-clinical and/or trial readiness activities are desired, applicants should consider the companion NOFO which utilizes an R61/R33 phased approach.

Minnesota's main training grant option, the Partnership program, focuses on providing training for both new and existing employees of participating businesses throughout the state. Minnesota participating businesses must partner with an accredited Minnesota educational institution. Grants of up to $400,000 are awarded to the educational institution to develop and deliver custom training specific to business needs. A cash or in-kind contribution from the participating business must match the grant funds on at least a one-to-one basis. Funds may be used for training-related costs such as curriculum development, instruction, training materials and supplies, training equipment, and instructor travel. Requests for wage subsidies and tuition reimbursement are not eligible. However, wages paid to employees during training may be counted towards the required matching contribution.